These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Coexisting cholinergic and parahippocampal degeneration: a key to memory loss in dementia and a challenge for transgenic models? Cassel JC; Mathis C; Majchrzak M; Moreau PH; Dalrymple-Alford JC Neurodegener Dis; 2008; 5(5):304-17. PubMed ID: 18520165 [TBL] [Abstract][Full Text] [Related]
6. Genetic deletion or antagonism of kinin B(1) and B(2) receptors improves cognitive deficits in a mouse model of Alzheimer's disease. Prediger RD; Medeiros R; Pandolfo P; Duarte FS; Passos GF; Pesquero JB; Campos MM; Calixto JB; Takahashi RN Neuroscience; 2008 Feb; 151(3):631-43. PubMed ID: 18191900 [TBL] [Abstract][Full Text] [Related]
7. Differential effects of cyclooxygenase inhibitors on intracerebroventricular colchicine-induced dysfunction and oxidative stress in rats. Kumar A; Seghal N; Padi SV; Naidu PS Eur J Pharmacol; 2006 Dec; 551(1-3):58-66. PubMed ID: 17027965 [TBL] [Abstract][Full Text] [Related]
8. [Depression and frontal dysfunction: risks for the elderly?]. Thomas P; Hazif Thomas C; Billon R; Peix R; Faugeron P; Clément JP Encephale; 2009 Sep; 35(4):361-9. PubMed ID: 19748373 [TBL] [Abstract][Full Text] [Related]
9. Disease progression in vascular cognitive impairment: cognitive, functional and behavioural outcomes in the Consortium to Investigate Vascular Impairment of Cognition (CIVIC) cohort study. Rockwood K; Moorhouse PK; Song X; MacKnight C; Gauthier S; Kertesz A; Montgomery P; Black S; Hogan DB; Guzman A; Bouchard R; Feldman H; J Neurol Sci; 2007 Jan; 252(2):106-12. PubMed ID: 17189642 [TBL] [Abstract][Full Text] [Related]
10. Relationship of the Ubiquilin 1 gene with Alzheimer's and Parkinson's disease and cognitive function. Arias-Vásquez A; de Lau L; Pardo L; Liu F; Feng BJ; Bertoli-Avella A; Isaacs A; Aulchenko Y; Hofman A; Oostra B; Breteler M; van Duijn C Neurosci Lett; 2007 Aug; 424(1):1-5. PubMed ID: 17709205 [TBL] [Abstract][Full Text] [Related]
12. Proton magnetic resonance spectroscopy in dementias and mild cognitive impairment. Griffith HR; Stewart CC; den Hollander JA Int Rev Neurobiol; 2009; 84():105-31. PubMed ID: 19501715 [TBL] [Abstract][Full Text] [Related]
13. The basis for disease-modifying treatments for Alzheimer's disease: the Sixth Annual Mild Cognitive Impairment Symposium. Duara R; Barker W; Loewenstein D; Bain L Alzheimers Dement; 2009 Jan; 5(1):66-74. PubMed ID: 19118811 [TBL] [Abstract][Full Text] [Related]
14. Transgenic animal models of neurodegenerative diseases and their application to treatment development. Rockenstein E; Crews L; Masliah E Adv Drug Deliv Rev; 2007 Sep; 59(11):1093-102. PubMed ID: 17869376 [TBL] [Abstract][Full Text] [Related]